Latest News for: Coagulation factors

Edit

Biotest AG opens 12th plasma collection centre in Germany

Pharmiweb 19 Apr 2024
EQS-News. Biotest AG / Key word(s). Miscellaneous. Biotest AG opens 12th plasma collection centre in Germany. 19.04.2024 / 09.00 CET/CEST ...   ... Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma ... .
Edit

Hemophilia A Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies and Companies by DelveInsight | ...

GetNews 16 Apr 2024
Patients who are injured cannot stop bleeding unless these factors are present ... By Molecule Type Small molecules Gene Therapies Bispecific antibodies Recombinant proteins Fusion Proteins Coagulants Blood coagulation factor replacements.
Edit

Biotest AG increased sales by 32% in the financial year 2023

Pharmiweb 28 Mar 2024
EQS-News. Biotest AG / Key word(s). Annual Results. Biotest AG increased sales by 32% in the financial year 2023. 28.03.2024 / 12.38 CET/CEST ... Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma ... Phone.
Edit

What happens if a rattlesnake bites you? Here's everything you should and shouldn't do

Azcentral 23 Mar 2024
Then they do bloodwork to test for coagulation factors because one of the things from rattlesnake venom is it can cause your blood to kind of congeal inside your body and that can cause problems like stroke.
Edit

Plasma Fractionation Market Expansion: Anticipated To Reach USD 57.0 Billion By 2032, Reflecting A 7.3% Growth Rate

Pharmiweb 22 Mar 2024
Immunoglobulins lead, trailed by coagulation factors and albumin ... Albumin Immunoglobulins Coagulation Factors Protease Inhibitors Other Product Types By Method ... and leverage factors that drive growth.
Edit

Plasma Fractionation Market Size, Opportunities, Share, Top Companies Analysis, Growth, Regional Trends, Key Segments, Graph ...

GetNews 21 Mar 2024
Based on product, the plasma fractionation market is segmented into protease inhibitors, coagulation factor concentrates, immunoglobulins, albumins, and other products.
Edit

Plasma Fractionation Market Applications, Growth, Size, Opportunities, Top Players, Share, Trends, Segmentations, Regional Insights, Graph ...

GetNews 14 Mar 2024
Based on product, the plasma fractionation market is segmented into protease inhibitors, coagulation factor concentrates, immunoglobulins, albumins, and other products.
Edit

Plasma Fractionation Market worth $40.4 billion by 2028 | MarketsandMarkets

GetNews 13 Mar 2024
Based on product, the plasma fractionation market is segmented into protease inhibitors, coagulation factor concentrates, immunoglobulins, albumins, and other products.
Edit

This Is What Happens To The Body After Seven Days Without Food

IFL Science 02 Mar 2024
Advertisement ... Advertisement ... For instance, they observed an increase in coagulation factor XI, thus potentially heightening the risk of thrombosis events.  ... Advertisement. The study has been published in the journal Nature Metabolism ... .
Edit

Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark ...

GetNews 01 Mar 2024
Patients who are injured cannot stop bleeding unless these factors are present ... By Molecule Type Small molecules Gene Therapies Bispecific antibodies Recombinant proteins Fusion Proteins Coagulants Blood coagulation factor replacements.
Edit

Biotest achieves EBIT forecast for 2023

Pharmiweb 29 Feb 2024
EQS-News. Biotest AG / Key word(s). Preliminary Results. Biotest achieves EBIT forecast for 2023. 29.02.2024 / 07.45 CET/CEST ...  .   ...   ... Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma ... .
Edit

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care

Pharmiweb 28 Feb 2024
EQS-News. Biotest AG / Key word(s). Miscellaneous ... 28.02.2024 / 10.00 CET/CEST ...  .  .  .  . PRESS RELEASE.  .   ...   ... Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma ... Mail.
Edit

Plasma Fractionation Market worth $40.4 billion by 2028

GetNews 21 Feb 2024
Based on product, the plasma fractionation market is segmented into protease inhibitors, coagulation factor concentrates, immunoglobulins, albumins, and other products.
Edit

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate

Pharmiweb 14 Feb 2024
EQS-News. Biotest AG / Key word(s). Study results ... 14.02.2024 / 08.30 CET/CEST ... Fibrinogen is a blood clotting factor that is produced in the liver ... Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma.
Edit

Ask the doctors: Several treatments available for noseblleds

The Spokesman-Review 08 Feb 2024
Dear Doctors ... Dear Reader ... The thrombin spray you were treated with is one of several medications used to encourage what is known as a coagulation cascade. It works by activating proteins known as clotting factors, which stanch the flow of blood ... .
×